The graph is a simplified mathematical estimate based mainly on published half-life values and selected dosing schedules
The side effects are similar to semaglutide GLP-1, primarily gastrointestinal discomfort
A patient who begins GLP-1 therapy often experiences significant fatigue, nausea, and reduced appetite in the early weeks
Conditions that can raise your risk of hyperhidrosis include thyroid disease, diabetes, certain tumors, obesity, and even mercury poisoning, says Dr
Ongoing support: Many programs include coaching, community, and lifestyle guidance
Back Mojsov, S, Weir, GC, Habener, JF (Feb 1987) 'Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas', Journal of Clinical Investigation , 79, 616-19